Navigation Links
Express Scripts Reports Fourth Quarter Results
Date:2/22/2012

rized, $0.01 par value per share;   shares issued: 690,650,000 and 690,231,000, respectively; shares outstanding: 484,582,000 and 528,069,000, respectively

6.96.9 Additional paid-in capital

2,438.22,354.4 Accumulated other comprehensive income

17.019.8 Retained earnings

6,645.65,369.89,107.77,750.9 Common stock in treasury at cost, 206,068,000 and   162,162,000 shares, respectively

(6,634.0)(4,144.3)Total stockholders' equity

2,473.73,606.6Total liabilities and stockholders' equity

$ 15,607.0$ 10,557.8EXPRESS SCRIPTS, INC. Unaudited Consolidated Statement of Cash Flows Year Ended
December 31, (in millions)

20112010 Cash flows from operating activities: Net income  

$ 1,275.8$ 1,181.2 Net loss from discontinued operations, net of tax

-23.4Net income from continuing operations

1,275.81,204.6 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization

253.4244.7 Deferred income taxes

137.8110.4 Employee stock-based compensation expense

48.849.7 Bad debt expense

11.65.2 Deferred financing fees

81.05.1 Other, net

4.59.4 Changes in operating assets and liabilities:   Receivables

(206.1)793.0 Inventories

8.0(70.2) Other current and noncurrent assets

119.2(90.0) Claims and rebates payable

207.5(186.7) Other current and noncurrent liabilities

250.529.9 Net cash provided by operating activities — continuing operations

2,192.02,105.1 Net cash provided by operating activities — discontinued operations

-12.3 Net cash flows provided by operating activities

2,192.02,117.4 Cash flows from investing activities: Purchases of property and equipment

(144.4)(119.9) Purchase of short-term investments

(25.0)(38.0) Proceeds from sale of short-term investments

45
'/>"/>

SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
2. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
3. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
4. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
5. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
8. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
9. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
10. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- IGI Laboratories, Inc. (NYSE-MKT: IG), a New Jersey ... today at the Deutsche Bank 40th Annual Health Care Conference. ... and 7 th at The InterContinental Hotel, ... CEO and President and Jenniffer Collins , Chief Financial ... 2015, at 3:30 p.m. ET.   The presentation will be ...
(Date:5/6/2015)... --  Sigma-Aldrich Corporation (NASDAQ: SIAL ) a leading ... $50,000 product donation to the Reproducibility Project: Cancer ... from recent high-impact papers in the field of cancer ... research marketplace Science Exchange , the non-profit ... eLife. The goal of the project is ...
(Date:5/6/2015)... 2015   Symbiomix Therapeutics today announced multiple ... tranche of a $41 million Series A financing and ... testing a single oral dose of SYM-1219 for the ... the U.S. Food and Drug Administration (FDA) at an ... submit the Phase 2 trial as one of two ...
Breaking Medicine Technology:Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5
... (Nasdaq: ENDP ) announced today that it is ... of axomadol. Endo licensed exclusive rights to develop and market ... February 2009. "As a leader in the ... and commercialization of pain therapeutics," said Ivan Gergel, M.D., executive ...
... Endologix, Inc. (Nasdaq: ELGX ), developer and marketer ... Judge Tanya Walton Pratt of the United States District Court ... a Markman ruling in the ongoing patent infringement lawsuit filed ... a Markman ruling, the court determines the meaning of disputed ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Endologix Announces Favorable Markman Ruling in Cook Patent Litigation 2
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... Ace Care, has recently announced that they will now ... replacement, for strata complexes in addition to commercial and ... large scale and require a lot of technical knowledge ... “When we do an installation we will take away ...
(Date:5/6/2015)... Va. (PRWEB) May 06, 2015 ... in the state of Virginia to acquire Intuitive ... surgical robot. The system upgrade includes enhanced surgical ... minimally invasive procedures across a wide spectrum of ... options, reduced pain and quicker recovery times. , ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... The Beryl Institute announces the publication of ... (PXJ), an international, open access, peer-reviewed journal focused on ... experience. The second volume of PXJ supports the goal ... the voices engaged and provides the space for listening, ... The Beryl Institute, Volume 2, Issue 1 includes ...
(Date:5/6/2015)... Animals make just as good friends as they do pets. ... An Ohio veterinarian has been observing this for ... advantages of owning a pet. , “When animals and humans ... there are proven health benefits for people-- including physical, mental ... Animal Medical Center of Streetsboro said. Every May, ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... Colo., Sept. 11 ,Spectranetics Corporation (Nasdaq: SPNC ... A.G. Edwards Growth Conference, which is being held,September ... John G. Schulte, Spectranetics, president and chief executive ... at 9:30 a.m. Eastern time,(7:30 a.m. Mountain time) ...
... Board of Directors of,Bristol-Myers Squibb Company (NYSE: BMY ... per share on the $.10 par value,Common Stock of ... 1, 2007 to stockholders of record at the close ... declared a quarterly dividend of fifty cents ($0.50),per share ...
... Sept. 11 Washington state nursing,leader Sally Watkins, ... of,Nursing Practice, Education, and Research by the Washington ... professional nurses,association and union. "We are very ... leader,who will be a strong patient and nurse ...
... nuclear power industry is riding the green wave back ... solution to our growing energy needs. But even as ... realistically play, it is bound by a global energy ... by the marketplace. , Veteran New York Times ...
... a third of prostate biopsies resulted in a cancer ... Men whose first biopsy did not find cancer often ... chance of a cancer diagnosis. , While PSA ... cancer screening, a biopsy is what actually determines the ...
... at the University of Oregon and requiring no more ... after a doctors appointment is credited with a 224-percent ... mild developmental delays in a yearlong study. , Researchers ... referrals for special services or additional monitoring would not ...
Cached Medicine News:Health News:Spectranetics to Present at The A.G Edwards Growth Conference on September 18 2Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Parental surveys boost diagnosis abilities of pediatricians 2Health News:Parental surveys boost diagnosis abilities of pediatricians 3
... Sterile E*Kits® can be a valuable ... care; when the items necessary for a ... facility protocols and continuum of care are ... are packaged in sequence of use, allowing ...
... trays to dry trays to specialty vaginal ... Cardinal Health offers the widest offering in ... components that are proven to be safe ... of surgical site infections. Cardinal Health Scrub ...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Panel consists of plasma specimens with reactivity ... antibodies to HTLV I and II. This ... and diagnostic laboratories to evaluate their anti-HTLV ... test systems are included for comparative analysis ...
Medicine Products: